Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 32532 | 107 | 32.5 | 87% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | LAPTM4B | Author keyword | 65 | 93% | 23% | 25 |
| 2 | LAPTM4B 35 | Author keyword | 8 | 100% | 5% | 5 |
| 3 | LYSOSOMAL PROTEIN TRANSMEMBRANE 4 BETA | Author keyword | 6 | 100% | 4% | 4 |
| 4 | LYSOSOME ASSOCIATED PROTEIN TRANSMEMBRANE 4 BETA | Author keyword | 6 | 100% | 4% | 4 |
| 5 | BIRTH CONTROL | Address | 1 | 50% | 2% | 2 |
| 6 | TMEM92 | Author keyword | 1 | 100% | 2% | 2 |
| 7 | HOTP | Author keyword | 1 | 50% | 1% | 1 |
| 8 | HYBRID MRNA | Author keyword | 1 | 50% | 1% | 1 |
| 9 | INTERNAL MED MOL SCI 2 | Address | 1 | 50% | 1% | 1 |
| 10 | LAPTM4A | Author keyword | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | LAPTM4B | 65 | 93% | 23% | 25 | Search LAPTM4B | Search LAPTM4B |
| 2 | LAPTM4B 35 | 8 | 100% | 5% | 5 | Search LAPTM4B+35 | Search LAPTM4B+35 |
| 3 | LYSOSOMAL PROTEIN TRANSMEMBRANE 4 BETA | 6 | 100% | 4% | 4 | Search LYSOSOMAL+PROTEIN+TRANSMEMBRANE+4+BETA | Search LYSOSOMAL+PROTEIN+TRANSMEMBRANE+4+BETA |
| 4 | LYSOSOME ASSOCIATED PROTEIN TRANSMEMBRANE 4 BETA | 6 | 100% | 4% | 4 | Search LYSOSOME+ASSOCIATED+PROTEIN+TRANSMEMBRANE+4+BETA | Search LYSOSOME+ASSOCIATED+PROTEIN+TRANSMEMBRANE+4+BETA |
| 5 | TMEM92 | 1 | 100% | 2% | 2 | Search TMEM92 | Search TMEM92 |
| 6 | HOTP | 1 | 50% | 1% | 1 | Search HOTP | Search HOTP |
| 7 | HYBRID MRNA | 1 | 50% | 1% | 1 | Search HYBRID+MRNA | Search HYBRID+MRNA |
| 8 | LAPTM4A | 1 | 50% | 1% | 1 | Search LAPTM4A | Search LAPTM4A |
| 9 | MICRORNA 139 | 1 | 50% | 1% | 1 | Search MICRORNA+139 | Search MICRORNA+139 |
| 10 | NON CODING MRNA | 1 | 50% | 1% | 1 | Search NON+CODING+MRNA | Search NON+CODING+MRNA |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | TETRATRANSMEMBRANE PROTEIN | 20 | 100% | 8% | 9 |
| 2 | LAPTM4B 35 | 1 | 100% | 2% | 2 |
| 3 | LAPTM4B | 1 | 40% | 2% | 2 |
| 4 | LAPTM4B GENE POLYMORPHISM | 1 | 50% | 1% | 1 |
| 5 | MESSENGER RNA OVEREXPRESSION | 1 | 50% | 1% | 1 |
| 6 | B 1B | 0 | 33% | 1% | 1 |
| 7 | MONOZYGOTIC TWINS SUGGEST | 0 | 33% | 1% | 1 |
| 8 | SEEMS | 0 | 33% | 1% | 1 |
| 9 | MYELOID DIFFERENTIATION PROGRAM | 0 | 15% | 2% | 2 |
| 10 | ADAPTER PROTEIN 2 | 0 | 17% | 1% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| Breakthrough cancer medicine and its impact on novel drug development in China: report of the US Chinese Anti-Cancer Association (USCACA) and Chinese Society of Clinical Oncology (CSCO) Joint Session at the 17th CSCO Annual Meeting | 2014 | 0 | 11 | 27% |
| Non-coding mRNA. | 1998 | 0 | 5 | 20% |
| On the horizon: Flexible immune recognition outside lymphocytes | 2013 | 1 | 60 | 7% |
| Extralymphocytic Flexible Immune Recognition: a New Angle on Inflammation and Aging | 2012 | 1 | 64 | 6% |
| Innate versus adaptive immunity: A paradigm past its prime? | 2007 | 27 | 37 | 3% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | BIRTH CONTROL | 1 | 50% | 1.9% | 2 |
| 2 | INTERNAL MED MOL SCI 2 | 1 | 50% | 0.9% | 1 |
| 3 | MINIST EDUC ONCOL CARCINOGENESIS TR | 1 | 50% | 0.9% | 1 |
| 4 | PEDIAT PATHOL MICROBIOL | 1 | 50% | 0.9% | 1 |
| 5 | TRANS IPTOME PROTEOME HUMAN DIS | 1 | 50% | 0.9% | 1 |
| 6 | INTERVENT RADIOL VASC SURG | 0 | 10% | 3.7% | 4 |
| 7 | MINIST EDUC CLIN | 0 | 33% | 0.9% | 1 |
| 8 | SENIOR OFFICIALS INPATIENT WARD | 0 | 33% | 0.9% | 1 |
| 9 | TMDT MARS | 0 | 33% | 0.9% | 1 |
| 10 | UROL KEY CLIN SPECIALTY UROL | 0 | 33% | 0.9% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000111511 | NESFATIN 1//NUCB2//NUCLEOBINDIN 2 |
| 2 | 0.0000096553 | NORPEG//N COPINE//PSGR |
| 3 | 0.0000085042 | MUCOLIPIDOSIS TYPE IV//MUCOLIPIN//MUCOLIPIDOSIS IV |
| 4 | 0.0000081756 | DANON DISEASE//LAMP 2 DEFICIENCY//LAMP 2 |
| 5 | 0.0000075599 | ASTROCYTE ELEVATED GENE 1//AEG 1//METADHERIN |
| 6 | 0.0000072048 | ARGININE DEIMINASE//ARGININE DEPRIVATION//ADI PEG20 |
| 7 | 0.0000054011 | DIFFERENTIAL GENE EXPRESSION DETECTION//CANCER OUTLIER PROFILE ANALYSIS//BREAST CANC DIAG TREATMENT HENAN |
| 8 | 0.0000049752 | SEX DISCRIMINATION OF CANCER RISK//STEROID CARCINOGENESIS//TUMOR SUPPRESSOR GENE INACTIVATION |
| 9 | 0.0000049566 | CLIC1//CHLORIDE INTRACELLULAR CHANNEL 1//CLIC4 |
| 10 | 0.0000048421 | KRUKENBERG TUMOR//OVARIAN METASTASIS//OVARIAN METASTASES |